GO:0070443 Mad-Max complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070443 (Mad-Max complex) is a cellular_component defined as a transcriptional repressor complex consisting of a heterodimer of the bHLH-ZIP proteins Mad and Max [1, 3].
• Mad-Max represses transcription by recruiting mammalian homologs of the yeast repressor Sin3, forming a ternary complex that brings histone deacetylase activity to target promoters [1, 2].
• The Mad-Max complex antagonizes Myc transcriptional activity and drives a switch from Myc:Max to Mad:Max heterocomplexes during monocyte/macrophage differentiation [4, 6].
• Mad-Max is central to the Myc/Max/Mad network, a regulatory hub controlling cell growth, proliferation, and differentiation [3, 5].
• Dysregulation of Mad-Max complex function has been linked to cancer biology, including glioblastoma, where transcriptional repression of Mad-Max by stem cells downregulates ERK signaling.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of Mad-Max complex components and their downstream targets [1, 2, 4].
Description
The Mad-Max complex (GO:0070443) is a transcriptional repressor complex that consists of a heterodimer of the bHLH-ZIP proteins Mad and Max [1, 3]. It is a key node in the Myc/Max/Mad network, a regulatory system that governs cell growth, proliferation, and differentiation [3, 5]. The complex was initially identified through the discovery that Mad serves as a heterodimeric partner for Max and antagonizes Myc transcriptional activity. Subsequent work demonstrated that Mad-Max represses transcription by forming a ternary complex with mammalian homologs of the yeast repressor Sin3. This recruitment of Sin3, in turn, brings histone deacetylase activity to target promoters, providing a direct link between the Mad-Max complex and chromatin-mediated transcriptional repression. The biological importance of the Mad-Max complex is underscored by the observation that a switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. This switch is thought to be a critical step in the transition from a proliferative to a differentiated state. For researchers, the Mad-Max complex represents a paradigm for understanding how bHLH-ZIP transcription factors assemble into combinatorial dimers to regulate gene expression programs. Its role in differentiation and its antagonism of Myc make it a compelling target for studies in cancer biology, developmental biology, and stem cell research [4, 7]. The availability of CRISPR-based tools now allows precise manipulation of Mad-Max complex components to test causal hypotheses in relevant cellular models [1, 2].
Mad-Max complex At A Glance
| GO ID | GO:0070443 |
|---|---|
| GO term | Mad-Max complex |
| Ontology | cellular_component |
| Synonym | None |
| Definition | A transcriptional repressor complex that consists of a heterodimer of the bHLH-ZIP proteins Mad and Max [1, 3]. |
| Major function | Transcriptional repression via recruitment of Sin3 and histone deacetylase activity [1, 2]. |
| Complex type | Heterodimer of bHLH-ZIP proteins [1, 3]. |
| Key components | Mad family proteins (e.g., MXD1/Mad1) and Max (MYC associated factor X) [1, 6]. |
| Biological context | Antagonizes Myc transcriptional activity; involved in differentiation [4, 6]. |
| Related network | Myc/Max/Mad network [3, 5]. |
What Is GO:0070443?
According to the Gene Ontology, GO:0070443 (Mad-Max complex) is a cellular_component defined as a transcriptional repressor complex that consists of a heterodimer of the bHLH-ZIP proteins Mad and Max [1, 3]. In other words, it is a protein complex formed by the dimerization of a Mad family protein with Max, which functions to repress transcription of target genes. The complex is part of the larger Myc/Max/Mad network of bHLH-ZIP transcription factors [3, 5].
Why Is Mad-Max complex Important in Cell Biology?
The Mad-Max complex is important because it serves as a central transcriptional repressor in the Myc/Max/Mad network, which controls fundamental cellular decisions such as proliferation, growth, and differentiation [3, 5]. Its ability to antagonize Myc activity and to recruit histone deacetylase activity through Sin3 provides a direct mechanism for chromatin-mediated gene silencing [1, 2]. The switch from Myc:Max to Mad:Max heterocomplexes during monocyte/macrophage differentiation highlights its role in developmental transitions. Dysregulation of this complex has been implicated in cancer, including glioblastoma, where transcriptional repression of Mad-Max by stem cells downregulates ERK signaling. Thus, understanding the Mad-Max complex is essential for both basic research in gene regulation and for translational studies in oncology and regenerative medicine [3, 7].
• Central repressor in the Myc/Max/Mad network controlling cell growth and proliferation [3, 5].
• Recruits Sin3 and histone deacetylase to target promoters, linking transcription factors to chromatin modification [1, 2].
• Antagonizes Myc transcriptional activity, thereby influencing cell cycle progression.
• Drives differentiation-associated gene expression programs, as shown in monocyte/macrophage differentiation.
• Implicated in cancer biology, including glioblastoma, through regulation of ERK signaling.
• Provides a model for combinatorial bHLH-ZIP dimer specificity and transcriptional regulation.
• Potential target for therapeutic modulation in cancers with Myc overexpression [3, 6].
• Key to understanding stem cell differentiation and tissue homeostasis.
• Enables mechanistic studies of chromatin-mediated repression via HDAC recruitment.
• Serves as a paradigm for studying how dimerization partners dictate transcription factor function [1, 6].
Structure and Composition of Mad-Max complex
bHLH-ZIP domain architecture
In simple terms: Mad and Max proteins have special structural domains that allow them to pair up and bind DNA.
The Mad-Max complex is formed by heterodimerization of a Mad family protein and Max through their bHLH-ZIP domains [1, 3]. The basic region mediates DNA binding, the helix-loop-helix domain facilitates dimerization, and the leucine zipper stabilizes the dimer. This architecture is shared with other members of the Myc/Max/Mad network, allowing combinatorial dimer formation [3, 5].
Mad family proteins
In simple terms: Mad proteins are the partners that bring repressive functions to the complex.
Mad (MXD1) was identified as a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Other Mad family proteins can also dimerize with Max, but the canonical Mad-Max complex refers to the heterodimer of Mad and Max [1, 3]. The Mad protein contains a Sin3-interacting domain that is essential for transcriptional repression.
Max as a central hub
In simple terms: Max is a common partner that can pair with either Myc or Mad, acting as a switch.
Max serves as a central dimerization partner in the network, capable of forming heterodimers with Myc, Mad, and other bHLH-ZIP proteins [3, 5]. The relative abundance of Myc and Mad determines whether Max participates in activating (Myc:Max) or repressing (Mad:Max) complexes. This competitive dimerization is a key regulatory mechanism.
Ternary complex with Sin3
In simple terms: The Mad-Max complex recruits additional proteins to repress genes.
Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. This ternary complex then recruits histone deacetylase activity, leading to chromatin compaction and transcriptional repression. The assembly of this repressor complex is a critical step in Mad-Max function [1, 2].
Key Genes Involved in GO:0070443 Mad-Max complex
The following genes and proteins are key components or regulators of the Mad-Max complex and the broader Myc/Max/Mad network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MXD1 (Mad1) | Forms heterodimer with Max; recruits Sin3 to repress transcription [1, 6] | Core component of the Mad-Max complex; target for knockout and knock-in studies [1, 6] |
| MAX | Central bHLH-ZIP dimerization partner for Myc, Mad, and other proteins [3, 5] | Essential for all network complexes; knockout is lethal; key for interaction studies [3, 5] |
| MYC | Activates transcription as Myc:Max heterodimer; antagonized by Mad-Max | Oncogene; target for overexpression and point mutation studies |
| SIN3A | Scaffold protein recruited by Mad-Max to form ternary repressor complex | Mediates HDAC recruitment; target for knockout to disrupt repression |
| SIN3B | Paralog of SIN3A; component of Sin3 corepressor complex | Potential redundancy with SIN3A; knockout models to study repression |
| HDAC1 | Histone deacetylase recruited by Sin3 to repress transcription | Enzymatic effector of Mad-Max repression; target for inhibitors |
| HDAC2 | Histone deacetylase recruited by Sin3 to repress transcription | Enzymatic effector of Mad-Max repression; target for inhibitors |
| MXD4 (Mad4) | Mad family member; heterodimerizes with Max | May contribute to Mad-Max-like repressive complexes |
| MNT | bHLH-ZIP protein related to Mad; interacts with Max | Alternative Max partner; studied in differentiation |
| MLX | bHLH-ZIP protein that can interact with Mad | Potential alternative dimerization partner |
| SP1 | Transcription factor that can cooperate with Mad-Max at promoters | Context-dependent co-regulator |
| ERK1 (MAPK3) | Kinase downregulated upon Mad-Max repression in glioblastoma | Downstream signaling node; target for combination studies |
| ERK2 (MAPK1) | Kinase downregulated upon Mad-Max repression in glioblastoma | Downstream signaling node; target for combination studies |
| CDKN1A (p21) | Cell cycle inhibitor potentially regulated by Mad-Max | Marker of growth arrest; target for expression studies |
| CDKN2B (p15) | Cell cycle inhibitor potentially regulated by Mad-Max | Marker of growth arrest; target for expression studies |
| GAPDH | Housekeeping gene; used as control in expression studies | Reference gene for qPCR and RNA-seq |
| ACTB | Housekeeping gene; used as control in expression studies | Reference gene for qPCR and RNA-seq |
How Is Mad-Max complex Regulated?
The formation and activity of the Mad-Max complex are regulated at multiple levels. The relative abundance of Mad and Myc proteins determines the composition of Max-containing heterodimers, with a switch from Myc:Max to Mad:Max occurring during monocyte/macrophage differentiation. This switch is thought to be driven by changes in gene expression during differentiation. The transcriptional repression activity of Mad-Max is dependent on recruitment of Sin3 and histone deacetylase activity, which can be modulated by cellular signaling pathways [1, 2]. In glioblastoma, transcriptional repression of Mad-Max by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase (ERK) signaling, indicating that external cues can regulate Mad-Max activity. However, this specific study has been retracted, so the finding should be interpreted with caution. Post-translational modifications and protein stability of Mad and Max may also influence complex formation, though specific mechanisms are not fully defined in the cited literature.
Mad-Max complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MXD1 (Mad1) | Cancer; differentiation | Knockout and overexpression in cancer cell lines [1, 6] |
| MYC | Cancer (e.g., lymphoma, glioblastoma) | Point mutation and overexpression models |
| MAX | Cancer; developmental disorders | Knockout and knock-in models [3, 5] |
| SIN3A | Cancer; transcriptional regulation | Knockout to disrupt Mad-Max repression |
| ERK1/2 | Glioblastoma; MAPK signaling | Knockout and inhibitor studies |
Cancer and the Myc/Max/Mad network
The Mad-Max complex antagonizes Myc transcriptional activity, and disruption of this balance is implicated in cancer [3, 6]. Myc overexpression or Mad loss can shift the equilibrium toward proliferation, contributing to tumorigenesis. In glioblastoma, a study reported that transcriptional repression of Mad-Max by human umbilical cord blood stem cells downregulates ERK signaling, suggesting a role in tumor suppression. However, this study has been retracted, so the findings require independent validation. The Myc/Max/Mad network remains a major focus in cancer research.
Differentiation and developmental disorders
The switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation, indicating a role in normal development. Disruption of this switch could lead to differentiation defects, though specific developmental disorders linked to Mad-Max mutations are not well characterized in the cited literature. The network is also involved in stem cell differentiation and tissue homeostasis.
Glioblastoma and ERK signaling
In glioblastoma, Mad-Max complex activity has been linked to downregulation of extracellular signal-regulated kinase (ERK) signaling. This suggests that Mad-Max may suppress tumor growth through inhibition of MAPK pathways. However, the primary study has been retracted, so the association should be considered preliminary. Further research is needed to establish causality.
From Mad-Max complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Mad-Max complex formation require MXD1? | MXD1 knockout cell lines [1, 6] |
| What is the effect of Mad-Max on target gene expression? | Overexpression of MXD1 and MAX [1, 6] |
| How does Mad-Max recruitment of Sin3 affect chromatin? | SIN3A knockout or knock-in of Sin3-interaction domain mutants [1, 2] |
| Does Mad-Max antagonize Myc-driven proliferation? | Myc overexpression with Mad-Max induction |
| What is the role of Mad-Max in differentiation? | Differentiation models (e.g., monocyte/macrophage) with knockout |
| Does Mad-Max regulate ERK signaling in glioblastoma? | Glioblastoma cell lines with Mad-Max overexpression or knockout |
How to Study the Mad-Max complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Luciferase reporter assay | Transcriptional repression activity | Test Mad-Max effect on target promoters [1, 6] |
| Co-immunoprecipitation | Protein-protein interactions | Detect Mad-Max and Sin3 ternary complex |
| ChIP-seq | Genome-wide DNA binding | Map Mad-Max occupancy [1, 2] |
| HDAC activity assay | Histone deacetylase enzymatic activity | Measure repression machinery recruitment |
| RNA-seq | Global gene expression changes | Identify Mad-Max target genes [4, 5] |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Discover modifiers of Mad-Max function [1, 2] |
| Western blot | Protein expression and modification | Validate knockout and overexpression [6, 7] |
| qRT-PCR | mRNA expression levels | Validate RNA-seq findings |
Transcriptional repression assays
Luciferase reporter assays using promoters containing Mad-Max binding sites (E-boxes) can measure transcriptional repression [1, 6]. Chromatin immunoprecipitation (ChIP) can confirm Mad-Max occupancy at target promoters. These methods are foundational for studying Mad-Max function [1, 2].
Protein interaction studies
Co-immunoprecipitation (co-IP) and pull-down assays can detect Mad-Max heterodimers and ternary complexes with Sin3. Yeast two-hybrid and mammalian two-hybrid systems can map interaction domains. Structural studies such as X-ray crystallography and NMR have provided insights into bHLH-ZIP dimerization.
Chromatin and epigenetic analysis
Histone deacetylase activity associated with Mad-Max can be measured using HDAC activity assays. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) can map Mad-Max and HDAC occupancy genome-wide. These approaches link Mad-Max to chromatin modification.
Expression profiling and functional genomics
RNA-seq and microarray analysis can identify genes regulated by Mad-Max [4, 5]. CRISPR knockout screens can identify genes that modulate Mad-Max activity or are synthetic lethal with Mad-Max loss [1, 2]. These methods are powerful for dissecting the network.
How CRISPR Can Be Used to Study GO:0070443 Mad-Max complex
Knockout
CRISPR knockout of MXD1 or MAX can abolish Mad-Max complex formation, leading to derepression of target genes [1, 6]. Knockout of SIN3A disrupts the ternary repressor complex, mimicking loss of Mad-Max repression. These models are essential for testing the requirement of Mad-Max components in differentiation and proliferation.
Point Mutation
Point mutations in the DNA-binding domain of Mad or in the Sin3-interaction domain can dissociate DNA binding from repression [1, 3]. CRISPR-mediated point mutation knock-in allows precise structure-function analysis of the Mad-Max complex. Such models can reveal which residues are critical for heterodimerization or corepressor recruitment.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous MXD1 or MAX loci enables ChIP-grade antibodies and proteomic studies. Knock-in of fluorescent proteins allows live-cell imaging of Mad-Max complex dynamics. These models preserve endogenous regulation and stoichiometry.
Overexpression
Overexpression of MXD1 and MAX can drive formation of Mad-Max complexes and repress Myc target genes. Inducible overexpression systems allow temporal control of Mad-Max activity. Overexpression models are useful for studying the consequences of Mad-Max activation in cancer cells.
How EDITGENE Supports Mad-Max complex Research
Researchers studying Mad-Max complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, transcriptional repression, or downstream phenotypes such as differentiation and proliferation. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for Mad-Max complex research.
Frequently Asked Questions About Mad-Max complex
What is the Mad-Max complex?
The Mad-Max complex (GO:0070443) is a transcriptional repressor complex consisting of a heterodimer of the bHLH-ZIP proteins Mad and Max [1, 3].
What genes are involved in the Mad-Max complex?
Key genes include MXD1 (Mad1), MAX, and SIN3A, as well as HDAC1 and HDAC2 which are recruited for repression [1, 2, 6].
What is the function of the Mad-Max complex?
It represses transcription by recruiting Sin3 and histone deacetylase activity to target promoters, antagonizing Myc activity [1, 2, 6].
How does the Mad-Max complex repress transcription?
Mad-Max forms a ternary complex with Sin3, which recruits histone deacetylases to remove acetyl groups from histones, leading to chromatin compaction and gene silencing [1, 2].
What is the difference between Myc-Max and Mad-Max complexes?
Myc-Max activates transcription, while Mad-Max represses it; the switch between them regulates proliferation versus differentiation [4, 6].
What diseases are associated with the Mad-Max complex?
Dysregulation has been implicated in cancer, including glioblastoma, though some findings have been retracted [7, 8].
How can I study the Mad-Max complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of Mad-Max components [1, 3, 6].
What cell models are available for Mad-Max research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for MXD1, MAX, SIN3A, and related genes [1, 2, 6].
What is the role of Sin3 in the Mad-Max complex?
Sin3 is a corepressor recruited by Mad-Max to form a ternary complex that brings histone deacetylase activity to promoters.
Is the Mad-Max complex involved in differentiation?
Yes, a switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Conclusion
The Mad-Max complex (GO:0070443) is a central transcriptional repressor in the Myc/Max/Mad network, with critical roles in differentiation, proliferation, and cancer [1, 3, 4]. Its mechanism involves heterodimerization of Mad and Max, recruitment of Sin3, and histone deacetylase-mediated chromatin repression [1, 2]. Despite some retracted findings, the complex remains a high-priority research target [7, 8]. CRISPR-based models from EDITGENE enable precise functional studies to advance our understanding of this complex in health and disease [1, 2, 6].
References
- 1. Ayer DE et al.. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.. Cell 80(5):767-76 PMID: 7889570
- 2. Sommer A et al.. 1997. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity.. Curr Biol 7(6):357-65 PMID: 9197243
- 3. Nair SK et al.. 2006. Structural aspects of interactions within the Myc/Max/Mad network.. Curr Top Microbiol Immunol 302:123-43 PMID: 16620027
- 4. Ayer DE et al.. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.. Genes Dev 7(11):2110-9 PMID: 8224841
- 5. Hurlin PJ et al.. 1994. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.. Cold Spring Harb Symp Quant Biol 59:109-16 PMID: 7587059
- 6. Ayer DE et al.. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.. Cell 72(2):211-22 PMID: 8425218
- 7. Velpula KK et al.. 2012. Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.. Stem Cells Dev 21(10):1779-93 PMID: 21933022
- 8. Unknown. 2026. Retraction: Transcriptional Repression of Mad-Max Complex by Human Umbilical Cord Blood Stem Cells Downregulates Extracellular Signal-Regulated Kinase in Glioblastoma.. Stem Cells Dev PMID: 42544938
